FibroBiologics (FBLG) Receivables (2022)
FibroBiologics (FBLG) posted quarterly Receivables of $300000.0 for Q4 2022.
FibroBiologics (FBLG) Receivables (2022) Analysis & Trends
FibroBiologics has reported Receivables for 1 years, with the latest figure at $300000.0 in Q4 2022.
- Receivables for Q4 2022 came in at $300000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $300000.0 (changed N/A YoY), and the FY2022 annual result was $300000.0, changed N/A from the prior year.
- Receivables held at $300000.0 in Q4 2022.
- Over five years, Receivables peaked at $300000.0 in Q4 2022 and troughed at $300000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | FibroBiologics | 8.91 Mn | 8.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 300,000.00 |